718 related articles for article (PubMed ID: 33584726)
1. Intestinal Stem Cells and Immune Cell Relationships: Potential Therapeutic Targets for Inflammatory Bowel Diseases.
Hou Q; Huang J; Ayansola H; Masatoshi H; Zhang B
Front Immunol; 2020; 11():623691. PubMed ID: 33584726
[TBL] [Abstract][Full Text] [Related]
2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.
Lindemans CA; Calafiore M; Mertelsmann AM; O'Connor MH; Dudakov JA; Jenq RR; Velardi E; Young LF; Smith OM; Lawrence G; Ivanov JA; Fu YY; Takashima S; Hua G; Martin ML; O'Rourke KP; Lo YH; Mokry M; Romera-Hernandez M; Cupedo T; Dow L; Nieuwenhuis EE; Shroyer NF; Liu C; Kolesnick R; van den Brink MRM; Hanash AM
Nature; 2015 Dec; 528(7583):560-564. PubMed ID: 26649819
[TBL] [Abstract][Full Text] [Related]
4. Effects of Immune Cells on Intestinal Stem Cells: Prospects for Therapeutic Targets.
Ma L; Yu J; Zhang H; Zhao B; Zhang J; Yang D; Luo F; Wang B; Jin B; Liu J
Stem Cell Rev Rep; 2022 Oct; 18(7):2296-2314. PubMed ID: 35279803
[TBL] [Abstract][Full Text] [Related]
5. Innate Lymphoid Cells in Inflammatory Bowel Disease.
Li J; Glover SC
Arch Immunol Ther Exp (Warsz); 2018 Dec; 66(6):415-421. PubMed ID: 30155762
[TBL] [Abstract][Full Text] [Related]
6. T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage.
Takashima S; Martin ML; Jansen SA; Fu Y; Bos J; Chandra D; O'Connor MH; Mertelsmann AM; Vinci P; Kuttiyara J; Devlin SM; Middendorp S; Calafiore M; Egorova A; Kleppe M; Lo Y; Shroyer NF; Cheng EH; Levine RL; Liu C; Kolesnick R; Lindemans CA; Hanash AM
Sci Immunol; 2019 Dec; 4(42):. PubMed ID: 31811055
[TBL] [Abstract][Full Text] [Related]
7. IL22 Inhibits Epithelial Stem Cell Expansion in an Ileal Organoid Model.
Zwarycz B; Gracz AD; Rivera KR; Williamson IA; Samsa LA; Starmer J; Daniele MA; Salter-Cid L; Zhao Q; Magness ST
Cell Mol Gastroenterol Hepatol; 2019; 7(1):1-17. PubMed ID: 30364840
[TBL] [Abstract][Full Text] [Related]
8. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense.
Farache J; Zigmond E; Shakhar G; Jung S
Immunol Cell Biol; 2013 Mar; 91(3):232-9. PubMed ID: 23399695
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation.
Cader MZ; Kaser A
Gut; 2013 Nov; 62(11):1653-64. PubMed ID: 24104886
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?
Asakura H; Suzuki K; Honma T
World J Gastroenterol; 2007 Apr; 13(15):2145-9. PubMed ID: 17465491
[TBL] [Abstract][Full Text] [Related]
11. Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration.
Sorrentino G; Perino A; Yildiz E; El Alam G; Bou Sleiman M; Gioiello A; Pellicciari R; Schoonjans K
Gastroenterology; 2020 Sep; 159(3):956-968.e8. PubMed ID: 32485177
[TBL] [Abstract][Full Text] [Related]
12. Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
Hiejima E; Kawai T; Nakase H; Tsuruyama T; Morimoto T; Yasumi T; Taga T; Kanegane H; Hori M; Ohmori K; Higuchi T; Matsuura M; Yoshino T; Ikeuchi H; Kawada K; Sakai Y; Kitazume MT; Hisamatsu T; Chiba T; Nishikomori R; Heike T
Inflamm Bowel Dis; 2015 Jul; 21(7):1529-40. PubMed ID: 25946569
[TBL] [Abstract][Full Text] [Related]
13. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD.
Liu H; Dasgupta S; Fu Y; Bailey B; Roy C; Lightcap E; Faustin B
BMC Immunol; 2019 Nov; 20(1):42. PubMed ID: 31718550
[TBL] [Abstract][Full Text] [Related]
14. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
Valatas V; Kolios G; Bamias G
Front Immunol; 2019; 10():583. PubMed ID: 30972074
[TBL] [Abstract][Full Text] [Related]
15. Molecular Manipulations and Intestinal Stem Cell-Derived Organoids in Inflammatory Bowel Disease.
Boye TL; Steenholdt C; Jensen KB; Nielsen OH
Stem Cells; 2022 May; 40(5):447-457. PubMed ID: 35365825
[TBL] [Abstract][Full Text] [Related]
16. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!
Pantazi E; Powell N
Front Immunol; 2019; 10():676. PubMed ID: 31024537
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the mucosal immune system in inflammatory bowel disease.
MacDermott RP
J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661
[TBL] [Abstract][Full Text] [Related]
18. Essential role of IFN-γ in T cell-associated intestinal inflammation.
Eriguchi Y; Nakamura K; Yokoi Y; Sugimoto R; Takahashi S; Hashimoto D; Teshima T; Ayabe T; Selsted ME; Ouellette AJ
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232288
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.
Bouguen G; Chevaux JB; Peyrin-Biroulet L
World J Gastroenterol; 2011 Feb; 17(5):547-56. PubMed ID: 21350703
[TBL] [Abstract][Full Text] [Related]
20. Roles of nAChR and Wnt signaling in intestinal stem cell function and inflammation.
Takahashi T
Int Immunopharmacol; 2020 Apr; 81():106260. PubMed ID: 32007796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
